Biotech executive and company builder; CFO and CBO @insitro; Board member @TesseraTx; ex-VC; previously @McKinsey @HarvardCCB
San Francisco
Joined April 2013
- Tweets40
- Following140
- Followers218
- Likes232
Honored and thrilled to welcome AI/ML rockstar Emily Fox to @insitro after decades across @Stanford @Apple and @UW. See more in the release below with comments from Emily and @DaphneKoller!
Mary Rozenman retweeted
Our CSO Philip Tagari recently joined @a16zBioHealth's @vijaypande for an exciting conversation on his multi-decade journey in drug discovery and the role #AI and data at scale are playing in moving from “hunting for” drugs to engineering safe and effective therapeutics.
"We're in this transition from finding [drugs] to designing [drugs]" - Philip Tagari, CSO at @insitro.
Phil recently joined @vijaypande, founding general partner at a16z Bio+Health, to discuss all things drug discovery and AI including:
the evolution of drug discovery methods
the opportunity for scalable personalized medicine
and how Phil transitioned his career from the laboratory, to major biopharma companies, and now to a startup environment.
Listen on Raising Health: a16z.com/podcast/the-power-o…
Mary Rozenman retweeted
We're thrilled to launch a new insitro.com, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.
Mary Rozenman retweeted
We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. businesswire.com/news/home/2…
Mary Rozenman retweeted
Biotech founded by Daphne Koller makes stir on eve of JPM conference with new papers on drugs for cancer, ALS, liver disease; poaches new CMO from Pfizer. trib.al/lKUkjRB
Thrilled to continue to share more about our work and progress at @insitro with a deep dive on our science heading into #JPM2024 ! Huge thanks to @matthewherper and @statnews for the profile! Come see more when @DaphneKoller presents at the conference Monday 3:30pm !
We’re excited to share @matthewherper’s new story in @statnews, which spotlights 3 new research papers posted online describing exciting developments emerging from our #ML platform across our core therapeutic areas. Read more below. #JPM24
Excited and proud to launch the new @insitro website in an attempt to break open the black box. Check it out and more to come!
We're thrilled to launch a new insitro.com, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.
A glimpse into our work @insitro with more to come! Huge congrats to the amazing group of insitrocytes on our journey to transform biology discovery for better medicines.
We're pleased to share a look into part of our biology discovery platform, CellPaint-POSH, an ML-enabled high-content pooled optical screening system. Our research shows pooled genetic screening w/ cellular imaging can enhance gene function understanding. biorxiv.org/content/10.1101/…
Mary Rozenman retweeted
insitro unveiled an inspiring new tradition to celebrate insitrocytes' commitment to our mission. Unique insitro anniversary blocks, awarded yearly, serve as symbols of our shared journey. Thank you to our world-class team working to transform #drugdiscovery. #ML #inVivoWeek2023
Mary Rozenman retweeted
It's go time! #inVivoWeek2023 officially started today at insitro with an incredible, inspiring fireside chat between trailblazing healthcare leader @SueDHellmann and our Founder & CEO @DaphneKoller. Brace yourself for a week of learning, collaboration & boundless #innovation!
Congratulations, @DaphneKoller! An amazing honor and all of us at @insitro are cheering for you! 🤩🙌🚀
We’re very proud to share that insitro CEO & Founder @DaphneKoller has been elected to the National Academy of Sciences in recognition of her pioneering contributions to Machine Learning. Congratulations to Daphne and her distinguished peers for this prestigious recognition! #ML
Thrilled with today’s news that Philip Tagari is joining @insitro as CSO and can’t wait to work together!
Big news today! insitro has appointed industry-leading scientist & drug hunter Philip Tagari as CSO. We’re very excited for Philip to partner with our founder & CEO @DaphneKoller and our world-class team as we transform drug discovery & development. bwnews.pr/3gRAazO
Great work by @mattrasmus and the software engineering team at @insitro featured in a recent AWS blog. Check it out!
I have always enjoyed my conversations with the smart folks at @insitro. In this post, @mattrasmus talks about their data science workflows that run on AWS Batch. aws.amazon.com/blogs/hpc/dat…
Thrilled to welcome four amazing leaders to @insitro — Jevan as CPO, @martha_rook as CTOO, @Tkaraletsos as VP DS/ML, Ellen as VP biomarker sciences. Want to work with them too? We’re hiring!
We are excited to welcome @martha_rook, @Tkaraletsos, Ellen Berg and Jevan Soo Lenox to our team! Learn more about how their collective expertise will make an impact at insitro here: businesswire.com/news/home/2…
Great to share some of our exciting science at @insitro. If this is up your alley, check us out - we are hiring for a number of roles across compute, cell biology, drug discovery, and G&A at insitro.com/careers. Join us!
Today our CEO and founder @DaphneKoller will keynote #BMVC2021 and Hervé will Spotlight at #MLCB2021. They will share new data suggesting #MachineLearning enables longitudinal phenotyping in live cells. Stream: bmvc2021-virtualconference.c…
Great additional color on @insitro open sourcing redun today from @mattrasmus
Today, I'm excited to share some work our team has been doing over the last few years at @insitro. It's a new tool for data science called redun. We describe the motivation and contributions in this post. github.com/insitro/redun/
Thrilled to announce redun, our first open-sourced workflow at @insitro built by @mattrasmus and team. We hope redun can be enabling to others working at the convergence of compute and multi-modal biologic data. If this is exciting - come join @DaphneKoller and our team!
We're excited to announce the open sourcing of redun, an expressive, efficient, and easy-to-use workflow framework designed to deal with complex, rapidly evolving scientific workflows spanning multiple data types. Read more here: insitro.medium.com/8b06b707a…
Mary Rozenman retweeted
Thank you to @statnews and @erbrod for this great feature on the addition of tech industry leader @tstocky to our team as VP Product! We’re thrilled to have Tom onboard as we scale our data product.
"Coming from tech, I’m used to big data problems with billions of users," said Insitro's Tom Stocky. "In biology, a lot of it is small data problems." buff.ly/390ToLJ
Huge thank you to our process engineering and imaging ML colleagues at @insitro for the fantastic automation update tour for the G&A leadership! Was great to confuse the lab team with @DaphneKoller, myself, and the BD, finance, and legal colleagues in lab coats... 👩🏻🔬
No, it's not opposite day at insitro! It's the G&A and Executive Leadership automation tour courtesy of our amazing process engineering team! Thank you to our PE and imaging #MachineLearning colleagues for giving us a peek into the new labs coming online later this year.
Mary Rozenman retweeted
Today, Tessera is proud to announce the appointment of new industry leaders who will help us pioneer the future of #GeneticMedicine to our Board of Directors. Welcome Elliott Sigal and Mary Rozenman @mmrozenman! businesswire.com/news/home/2…